KR100496606B1 - Composition for anti-cancer comprising poly- -glutamic acid - Google Patents

Composition for anti-cancer comprising poly- -glutamic acid Download PDF

Info

Publication number
KR100496606B1
KR100496606B1 KR1020040051680A KR20040051680A KR100496606B1 KR 100496606 B1 KR100496606 B1 KR 100496606B1 KR 1020040051680 A KR1020040051680 A KR 1020040051680A KR 20040051680 A KR20040051680 A KR 20040051680A KR 100496606 B1 KR100496606 B1 KR 100496606B1
Authority
KR
South Korea
Prior art keywords
cancer
poly
composition
glutamic acid
glutamic
Prior art date
Application number
KR1020040051680A
Other languages
Korean (ko)
Inventor
Moon Hee Sung
Chul Joong Kim
Ha Ryoung Poo
Jong Soo Lee
Chung Park
Yoon Ho Choi
Kumio Yokoigawa
Original Assignee
Bioleaders Corp
Korea Res Inst Of Bioscience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioleaders Corp, Korea Res Inst Of Bioscience filed Critical Bioleaders Corp
Priority to KR1020040051680A priority Critical patent/KR100496606B1/en
Application granted granted Critical
Publication of KR100496606B1 publication Critical patent/KR100496606B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/045—Organic compounds containing nitrogen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
KR1020040051680A 2004-07-02 2004-07-02 Composition for anti-cancer comprising poly- -glutamic acid KR100496606B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040051680A KR100496606B1 (en) 2004-07-02 2004-07-02 Composition for anti-cancer comprising poly- -glutamic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040051680A KR100496606B1 (en) 2004-07-02 2004-07-02 Composition for anti-cancer comprising poly- -glutamic acid

Publications (1)

Publication Number Publication Date
KR100496606B1 true KR100496606B1 (en) 2005-06-22

Family

ID=37303099

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040051680A KR100496606B1 (en) 2004-07-02 2004-07-02 Composition for anti-cancer comprising poly- -glutamic acid

Country Status (1)

Country Link
KR (1) KR100496606B1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100656560B1 (en) 2005-12-29 2006-12-11 주식회사 바이오리더스 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid
KR100835607B1 (en) 2006-11-01 2008-06-09 건국대학교 산학협력단 Pharmaceutical composition comprising G-polyglutamic acid for alleviating and treating coughing
WO2009035174A1 (en) * 2007-09-13 2009-03-19 Bioleaders Corporation Composition for treating or preventing atopic dermatitis comprising poly-gamma-glutamic acid
WO2009035173A1 (en) * 2007-09-13 2009-03-19 Bioleaders Corporation Composition for preventing virus infection comprising poly-gamma-glutamic acid
WO2009048192A1 (en) * 2007-10-12 2009-04-16 Bioleaders Corporation Composition for improving tlr-mediated cellular immunity comprising poly-gamma-glutamic acid
WO2009088118A1 (en) * 2008-01-07 2009-07-16 Bioleaders Corporation Pharmaceutical composition for treating corneal wound comprising poly-gamma-glutamic acid
WO2009088119A1 (en) * 2008-01-07 2009-07-16 Bioleaders Corporation Composition for preventing or treating dry eye syndrome comprising poly-gamma-glutamic acid
US8916141B2 (en) 2005-10-20 2014-12-23 Bioleaders Corporation Hyaluronidase inhibitor containing poly-gamma-glutamic acid as an effective component
US9314520B2 (en) 2009-06-25 2016-04-19 Bioleaders Corporation Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles
KR101765600B1 (en) * 2016-04-18 2017-08-07 주식회사 바이오리더스 USE of Poly-gamma-glutamic Acid for Treating Cervical Intraepithelial Neoplasia
WO2018110713A1 (en) * 2016-12-12 2018-06-21 주식회사 이뮤니스바이오 Massive proliferation method for natural killer cells using macrophages and inflammatory substances
KR20190109853A (en) * 2018-03-19 2019-09-27 부경대학교 산학협력단 Method of producing poly gamma glutamic acid-containing fermented product
WO2020004810A1 (en) * 2018-06-26 2020-01-02 국민대학교산학협력단 METHOD FOR PREPARING BIOCOMPATIBLE POLY-γ-GLUTAMIC ACID HYDROGEL BY USING ULTRAVIOLET RAYS
US11111340B2 (en) 2018-06-26 2021-09-07 Kookmin University Industry Academy Cooperation Foundation Method for preparing biocompatible poly-γ-glutamic acid hydrogel by using ultraviolet rays

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8916141B2 (en) 2005-10-20 2014-12-23 Bioleaders Corporation Hyaluronidase inhibitor containing poly-gamma-glutamic acid as an effective component
US8618057B2 (en) 2005-12-29 2013-12-31 Bioleaders Corporation Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid
WO2007075017A1 (en) * 2005-12-29 2007-07-05 Bioleaders Corporation Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid
KR100656560B1 (en) 2005-12-29 2006-12-11 주식회사 바이오리더스 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid
KR100835607B1 (en) 2006-11-01 2008-06-09 건국대학교 산학협력단 Pharmaceutical composition comprising G-polyglutamic acid for alleviating and treating coughing
WO2009035173A1 (en) * 2007-09-13 2009-03-19 Bioleaders Corporation Composition for preventing virus infection comprising poly-gamma-glutamic acid
WO2009035174A1 (en) * 2007-09-13 2009-03-19 Bioleaders Corporation Composition for treating or preventing atopic dermatitis comprising poly-gamma-glutamic acid
US9095605B2 (en) 2007-09-13 2015-08-04 Bioleaders Corporation Composition for preventing virus infection comprising poly-gamma-glutamic acid
WO2009048192A1 (en) * 2007-10-12 2009-04-16 Bioleaders Corporation Composition for improving tlr-mediated cellular immunity comprising poly-gamma-glutamic acid
WO2009088118A1 (en) * 2008-01-07 2009-07-16 Bioleaders Corporation Pharmaceutical composition for treating corneal wound comprising poly-gamma-glutamic acid
WO2009088119A1 (en) * 2008-01-07 2009-07-16 Bioleaders Corporation Composition for preventing or treating dry eye syndrome comprising poly-gamma-glutamic acid
US9314520B2 (en) 2009-06-25 2016-04-19 Bioleaders Corporation Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles
KR101765600B1 (en) * 2016-04-18 2017-08-07 주식회사 바이오리더스 USE of Poly-gamma-glutamic Acid for Treating Cervical Intraepithelial Neoplasia
US10485823B2 (en) 2016-04-18 2019-11-26 Bioleaders Corporation Method for treating cervical intraepithelial neoplasia using poly-gamma- glutamic acid
WO2018110713A1 (en) * 2016-12-12 2018-06-21 주식회사 이뮤니스바이오 Massive proliferation method for natural killer cells using macrophages and inflammatory substances
KR20190109853A (en) * 2018-03-19 2019-09-27 부경대학교 산학협력단 Method of producing poly gamma glutamic acid-containing fermented product
KR102520365B1 (en) 2018-03-19 2023-04-10 부경대학교 산학협력단 Method of producing poly gamma glutamic acid-containing fermented product
WO2020004810A1 (en) * 2018-06-26 2020-01-02 국민대학교산학협력단 METHOD FOR PREPARING BIOCOMPATIBLE POLY-γ-GLUTAMIC ACID HYDROGEL BY USING ULTRAVIOLET RAYS
US11111340B2 (en) 2018-06-26 2021-09-07 Kookmin University Industry Academy Cooperation Foundation Method for preparing biocompatible poly-γ-glutamic acid hydrogel by using ultraviolet rays

Similar Documents

Publication Publication Date Title
ZA200610793B (en) Azine-carboxamides as anti-cancer agent
IL177480A0 (en) Pharmaceutical composition
EP1765283A4 (en) Pharmaceutical compositions
GB0409375D0 (en) Phytoactive composition
EP1726304A4 (en) Solifenacin-containing composition
GB0425795D0 (en) Composition
GB0416861D0 (en) Composition
EP1820847A4 (en) Composition for cell frozen-storage
EP1805154A4 (en) Pharmaceutical compositions
KR100496606B1 (en) Composition for anti-cancer comprising poly- -glutamic acid
GB0410038D0 (en) Composition
GB0414803D0 (en) Composition
ZA200704974B (en) Composition
LT2985018T (en) Anti-discoloration composition
HU0401177D0 (en) Pharmaceutical composition
GB0415981D0 (en) Composition
GB2411355B (en) Pharmaceutical composition
GB0417357D0 (en) Composition
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
ZA200701931B (en) Pharmaceutical composition
EP1747205A4 (en) Pharmaceutical compositions
GB0417388D0 (en) Composition
GB0400971D0 (en) Pharmaceutical compositions
GB2418924B (en) Weathered-effect composition

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130614

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20140612

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20150612

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20160614

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20170207

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20180614

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20190403

Year of fee payment: 15